Network origin in Linda B. Hearne first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
| Public Company | Biotechnology | 21 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Linda B. Hearne via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Centocor, Inc.
 Centocor, Inc. Medical SpecialtiesHealth Technology Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA. | Medical Specialties | Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin | |
Vicuron Pharmaceuticals LLC
 Vicuron Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vicuron Pharmaceuticals LLC develops pharmaceutical products. It engages in discovering, developing, manufacturing, and commercializing vital medicine for seriously ill patients. The company offers anidulafungin drug, which prevents cell wall formation and other infectious fungi. It also offers antibiotic for the treatment of complicated skin and soft-tissue infections. The company was founded by Christopher T. Walsh in 1995 and is headquartered in King of Prussia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Eximias Pharmaceutical Corp.
 Eximias Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Eximias Pharmaceutical Corp. develops pharmaceuticals for treatment of cancer disorders. It offers its services in the mid-Atlantic areas. The company is headquartered in Berwyn, PA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
| NANOSPHERE, INC. | Medical Specialties | Director/Board Member Chairman | |
Agilvax, Inc.
 Agilvax, Inc. BiotechnologyHealth Technology Agilvax, Inc. discovers and develops immunotherapies to combat cancer and targeted vaccines against infectious diseases. It optimizes lead immunotherapy candidates through an extensive in vitro and in vivo testing process to ensure clinical efficacy. The company was founded in 2011 and is headquartered in Albuquerque, NM. | Biotechnology | Founder | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Masters Business Admin Graduate Degree | |
| University of Pennsylvania | College/University | Corporate Officer/Principal Undergraduate Degree Undergraduate Degree | |
| Boston University | College/University | Undergraduate Degree | |
| Iowa State University | College/University | Doctorate Degree Doctorate Degree | |
The Biotechnology Greenhouse Corp. of Southeastern PA
 The Biotechnology Greenhouse Corp. of Southeastern PA Investment ManagersFinance The Biotechnology Greenhouse Corp. of Southeastern PA (BioAdvance) is a venture capital firm founded in 2002. The firm is headquartered in Philadelphia, Pennsylvania. | Investment Managers | Director/Board Member Chief Operating Officer | |
| Beloit College | College/University | Undergraduate Degree | |
| Temple University (Pennsylvania) | College/University | Graduate Degree Graduate Degree | |
| Yale University | College/University | Undergraduate Degree Corporate Officer/Principal | |
| The Pennsylvania State University | College/University | Undergraduate Degree Director/Board Member Graduate Degree | |
| Siena College | College/University | Undergraduate Degree | |
| NEUROPACE, INC. | Medical Specialties | Director/Board Member | |
Biolipox AB
 Biolipox AB Pharmaceuticals: MajorHealth Technology Biolipox AB develops and manufactures pharmaceuticals products. The company engages in the research and development of pharmaceuticals for the treatment of respiratory and other inflammatory diseases such as asthma, chronic obstructive pulmonary disease, rhinitis, pain, and arthritis. It was founded in June 2000 and is headquartered in Solna, Sweden. | Pharmaceuticals: Major | President | |
Vicore Pharma AB
 Vicore Pharma AB Pharmaceuticals: MajorHealth Technology Vicore Pharma AB researches and develops pharmaceutical products. The company is headquartered in Gothenburg, Sweden. | Pharmaceuticals: Major | Chief Executive Officer | |
| SCHRÖDINGER, INC. | Packaged Software | Director/Board Member | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| NEVRO CORP. | Medical Specialties | Director/Board Member | |
| IBIO, INC. | Pharmaceuticals: Other | Director/Board Member | |
| Harvard Medical School | College/University | Doctorate Degree | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Financial Conglomerates | Private Equity Investor | |
| Janssen Supply Group LLC | Corporate Officer/Principal Corporate Officer/Principal | ||
| UROGEN PHARMA LTD. | Biotechnology | Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
| SPARK THERAPEUTICS, INC. | Biotechnology | General Counsel Founder | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
Elucida Oncology, Inc.
 Elucida Oncology, Inc. BiotechnologyHealth Technology Elucida Oncology, Inc. operates as a biotechnology company which focuses on clinical research and development. The company was founded by Isaac Blech, Michelle Bradbury, Ulrich Weisner, and Steven Larson in 2014 and is headquartered in Monmouth Junction, NJ. | Biotechnology | Director/Board Member | |
| HARMONY BIOSCIENCES HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Harmony Biosciences LLC
 Harmony Biosciences LLC Pharmaceuticals: MajorHealth Technology Harmony Biosciences LLC operates as a biopharmaceutical company which develops therapies to help patients with unmet medical needs. It provides novel treatment options to patients with orphan and rare conditions, with an emphasis on central nervous system disorders. The company is headquartered in Plymouth Meeting, PA. | Pharmaceuticals: Major | Director/Board Member | |
Treo Ventures LLC
 Treo Ventures LLC Investment ManagersFinance Treo Ventures LLC (Treo Ventures) is a venture capital firm founded in 2018 by Mudit K. Jain and Brad H. Vale. The firm is headquartered in Santa Clara, California, with an additional office in Dublin, Ireland. | Investment Managers | Founder | |
ProKidney LLC
 ProKidney LLC Packaged SoftwareTechnology Services ProKidney LLC develops therapies for kidney disease. The company was founded by Pablo Legorreta and is headquartered in Winston-Salem, NC. | Packaged Software | Director/Board Member Chief Executive Officer Chief Operating Officer | |
Tramway Venture Partners, Inc
 Tramway Venture Partners, Inc Investment ManagersFinance Tramway Ventures LLC (Tramway Venture) is a venture capital firm founded in 2017 by Waneta C. Tuttle. The firm is headquartered in Albuquerque, New Mexico. | Investment Managers | Private Equity Investor | |
Shiratronics, Inc.
 Shiratronics, Inc. Medical SpecialtiesHealth Technology Shiratronics, Inc. develops therapies to combat debilitating migraine headache. It focuses on commercializing novel neuromodulation technologies to treat this large unmet clinical need for patients and physicians. The company was founded by Lynn Elliott and Mudit K. Jain in 2019 and is headquartered in Saint Paul, MN. | Medical Specialties | Director/Board Member | |
| Merck & Co. | Real Estate Development | Investor Relations Contact | |
Healyx Labs, Inc.
 Healyx Labs, Inc. Medical SpecialtiesHealth Technology Healyx Labs, Inc. is an innovative medical device company, which engages in the implementation of wound healing. Its solutions include negative pressure wound therapy. The company was founded by Cam Hutton, Cassie Ludwig, Matias Rivera, and Tiffany Kung in 2015 ad is headquartered in Mountain View, CA. | Medical Specialties | Director/Board Member | |
Gennao Bio, Inc.
 Gennao Bio, Inc. Pharmaceuticals: MajorHealth Technology Gennao Bio, Inc. is a privately-held genetic medicines company that is developing first-in-class, non-viral, targeted nucleic acid therapeutics utilizing its proprietary gene monoclonal antibody (gmab) platform technology. The company is based in Pennington, NJ. The company's gmab technology uses a novel, cell-penetrating antibody to non-covalently bind to, and deliver therapeutic levels of a wide variety of nucleic acid payloads, to select cells. Gennao Bio is initially focusing on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases. The company's non-viral delivery platform offers significant advantages over traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and dose optimization, and can be easily and affordably manufactured. The company was founded in 2020 by Bruce Turner, Elias Quijano, Peter M. Glazer, Stephen P. Squinto. Christopher M. Duke has been the CEO of the company since 2021. | Pharmaceuticals: Major | Director/Board Member | |
| PROKIDNEY CORP. | Biotechnology | Director/Board Member Chief Executive Officer Chief Operating Officer | |
| SYNERGY PHARMACEUTICALS INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| New York University School of Medicine | College/University | Doctorate Degree |
Statistics
International
| United States | 41 |
| Sweden | 5 |
| United Kingdom | 4 |
| Israel | 2 |
| Austria | 2 |
Sectoral
| Health Technology | 28 |
| Consumer Services | 14 |
| Finance | 6 |
| Technology Services | 3 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 103 |
| Corporate Officer/Principal | 71 |
| Chief Executive Officer | 24 |
| Independent Dir/Board Member | 23 |
| Director of Finance/CFO | 16 |
Most connected contacts
| Insiders | |
|---|---|
| Gary Kurtzman | 30 |
| Brenda D. Gavin | 29 |
| Brad H. Vale | 28 |
| Brian Pereira | 23 |
| Carl-Johan Dalsgaard | 21 |
| Jeff Randall | 17 |
| James Nahirny | 15 |
| Tim Bertram | 15 |
| Gary Sender | 14 |
| Sharon Presnell | 13 |
| Joseph W. la Barge | 11 |
| Elyse G. Seltzer | 11 |
| A. Davis | 10 |
| Jeffrey D. Marrazzo | 10 |
| Mark Stejbach | 9 |
- Stock Market
- Insiders
- Linda B. Hearne
- Company connections
